Laquinimod enhances central nervous system barrier functions

Luhder, F; Kebir, H; Odoardi, F; Litke, T; Sonneck, M; Alvarez, JI; Winchenbach, J; Eckert, N; Hayardeny, L; Sorani, E; Lodygin, D; Flugel, A; Prat, A

Flugel, A (reprint author), Univ Gottingen, Max Planck Inst Expt Med, Inst Multiple Sclerosis Res & Neuroimmunol, Von Siebold Str 3A, D-37075 Gottingen, Germany.; Prat, A (reprint author), Notre Dame Hosp, CHUM Res Ctr, Room Y-3608,1560 Sherbrooke St East

NEUROBIOLOGY OF DISEASE, 2017; 102 ( ): 60

Abstract

Laquinimod is currently being tested as a therapeutic drug in multiple sclerosis. However, its exact mechanism of action is still under investigation.......

Full Text Link